CryoLife Increases Stake in Medafor, Inc. to Approximately 11 Percent

ATLANTA, Feb. 2 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has purchased approximately 740,000 additional shares of Medafor's common stock from Medafor shareholders for $2.00 per

http://digg.com/u1MAQn